Company profile for Bluejay Diagnostics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bluejay Diagnostics, Inc. is a late-stage, pre-revenue diagnostics/medical device company focused on improving patient outcomes through the Symphony System, a more cost-effective, rapid, near-patient product candidate for triage and monitoring of disease progression in hospital and long-term acute care (LTAC) settings. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patie...
Bluejay Diagnostics, Inc. is a late-stage, pre-revenue diagnostics/medical device company focused on improving patient outcomes through the Symphony System, a more cost-effective, rapid, near-patient product candidate for triage and monitoring of disease progression in hospital and long-term acute care (LTAC) settings. Bluejay Diagnostics is focused on improving patient outcomes through a more cost efficient, rapid, near patient product for triage, diagnosis, and monitoring of disease progression.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
360 Massachusetts Ave Suite 203Acton, MA 01720
Telephone
Telephone
844.327.7078
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/10/3184423/0/en/Bluejay-Diagnostics-Corporate-Update-Advancing-Clinical-Milestones-and-Strategic-Partnerships.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/10/3165124/0/en/Bluejay-Diagnostics-Announces-Closing-of-4-5-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
10 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3164535/0/en/Bluejay-Diagnostics-Announces-4-5-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/10/09/3163975/0/en/Bluejay-Diagnostics-and-SanyoSeiko-Expand-Strategic-Partnership-to-Advance-Commercialization-of-Symphony-Platform.html

GLOBENEWSWIRE
09 Oct 2025

https://www.globenewswire.com/news-release/2025/08/07/3129861/0/en/Bluejay-Diagnostics-Provides-Second-Quarter-Business-and-Corporate-Update.html

GLOBENEWSWIRE
07 Aug 2025

https://www.globenewswire.com/news-release/2025/06/03/3093179/0/en/Bluejay-Diagnostics-Provides-Mid-Year-Business-and-Corporate-Update.html

GLOBENEWSWIRE
03 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty